Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences introduces ANVIMO (Letermovir) for CMV prevention in transplant patients, offering a safer, ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Leveraging its World Health Organization (WHO)-prequalified Typhoid Conjugate Vaccine (ZyVac TCV) and a Shigella vaccine from ...

Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates ...

Typhoid is already a disease of concern globally and various endemic countries already have TCV as part of their national ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Pharma major, Zydus Lifesciences on Wednesday said that it has launched ANVIMO (Letermovir), a new and innovative treatment ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Zydus Lifesciences introduces ANVIMO, a cost-effective medication for preventing CMV infection in transplant patients, ...

Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone ...